CRH|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $2.25 | - | - |
| Q2'26 | $2.45 | $2.21 | -9.9% |
| Q4'25 | $1.54 | $1.52 | -1.1% |
| Q4'24 | $1.42 | $1.18 | -16.8% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $11.7B | - | - |
| Q2'26 | $10.8B | $10.8B | +0.2% |
| Q4'25 | $9.6B | $9.4B | -1.6% |
| Q4'24 | - | $8.9B | - |
Market Data
CRH Stock Snapshot
CRH is currently trading at $95.37, giving CRH PLC a market cap of 65.08B and a P/E ratio of 17.0. Today's range spans $94.63–$97.91, with shares opening at $97.88 and moving down $0.42 (0.4%) from the prior close. DailyIQ's technical score sits at 18/100 (SELL).
Over the past year CRH has traded between $92.52 and $131.55 - the current price is +3.1% off the 52-week low and -27.5% from the high. 29 analysts cover the stock with a Buy consensus and a mean 12-month target of $138.38 (range $105.00–$165.00), implying upside of +45.1%.
The options market is expressing concern about CRH - elevated put activity in large-cap Basic Materials names with SELL signals (18/100) is common when the technical and sentiment inputs (neutral, -/100) both deteriorate. Price: $95.37 (near 52-week lows). (P/E: 17.0) At 65.08B in capitalization, that hedging activity from institutional holders can become a feedback loop that amplifies the initial selling pressure. Range: $92.52–$131.55.
Analyst coverage for CRH becomes a double-edged factor in a SELL phase: at 65.08B in Basic Materials market cap, active coverage is high enough that downgrade risk is real and impactful. The 18/100 technical reading and neutral sentiment (-/100) at $95.37 (near 52-week lows) place the stock in the zone where one or two high-profile estimate cuts can convert a grinding decline into a sharper re-rating, the $92.52–$131.55 range establishes where that repricing lands.
Company Insights: CRH PLC (CRH)
CRH’s Q2 2026 revenue of $10.78 billion reflects a 15% year‑over‑year increase from Q4 2025’s $9.42 billion, illustrating robust top‑line momentum. The surge is largely driven by the $8.5 billion acquisition of Arcosa and the acquisition of Pisgah Stone Products, which have already begun to contribute incremental sales. Aggregate and cement volumes have grown consistently, with the company reporting a 6% YoY rise in Q4 2025 and a 15% jump in Q2 2026, reinforcing its core business strength. Despite the expansion, earnings per share lagged behind revenue, with EPS rising 45% to $2.21 but still missing analyst estimates, signaling potential margin pressure. This divergence between top‑line growth and earnings underscores the importance of monitoring integration costs and capital allocation decisions. Overall, the revenue trajectory positions CRH as a leading player in the building materials sector, poised to capture infrastructure and housing demand.
Margin expansion has been a key theme, as adjusted EBITDA margin grew to 24.4% in Q2 2026, up 30 basis points from the prior quarter. The improvement stems from higher product mix and cost efficiencies in logistics, yet the company’s net margin remains modest compared to peers. The Arcosa deal introduces significant financing costs, with debt levels expected to rise, potentially eroding profitability if interest rates climb. Nevertheless, the company’s strong cash flow generation and disciplined capital allocation provide a buffer against short‑term margin compression. Analysts remain cautious, noting that the integration of Arcosa’s operations could delay the realization of synergies for up to 12 months. Investors should watch for quarterly updates on debt servicing and the pace of cost‑saving initiatives to gauge the sustainability of the margin gains.
At a current share price of $100.10, CRH sits 19.9% above its 52‑week low and 14.2% below its high of $131.55, offering a modest upside corridor. The consensus analyst target of $138.65 implies roughly 38% upside from the current level, while the high target of $165.00 represents a potential 65% gain. Sentiment has been falling, with a 7‑point drop over the past 14 days, yet the overall score remains at 66, indicating a generally positive perception. Price returns over the past year have been negative at -11.1%, suggesting a lagging performance relative to the sector. However, the company’s valuation at a P/E of 17.4x is well below the peer average of 30.4x, indicating a discount that could be attractive if growth persists. These metrics together paint a picture of a growth story that is undervalued relative to its peers but still carries earnings volatility risks.
Revenue Momentum
CRH’s quarterly revenue climbed 15% YoY in Q2 2026, driven by the $8.5 billion Arcosa acquisition and organic volume growth across aggregates and cement.
The company’s top‑line expansion outpaces the sector average, positioning it to capture rising infrastructure spending in Europe and North America.
Continued growth hinges on sustaining volume gains amid rising input costs and integrating new product lines from Arcosa and Pisgah Stone.
Margin Dynamics
Adjusted EBITDA margin rose to 24.4% in Q2 2026, a 30‑basis‑point improvement, reflecting better product mix and cost controls.
Despite margin gains, net profitability remains modest, and the company’s debt‑to‑EBITDA ratio is projected to increase following the Arcosa transaction.
Monitoring debt servicing costs and the pace of synergies will be crucial to preserving margin expansion over the next 12 months.
Acquisition Impact
The $8.5 billion purchase of Arcosa expands CRH’s market share in North American aggregates, adding $2 billion of annual sales.
Integration risks include aligning supply chains, consolidating IT systems, and managing cultural differences across the combined workforce.
If successfully executed, the deal could unlock 5% revenue growth and improve economies of scale in logistics and procurement.
Valuation Edge
CRH trades at a forward P/E of 17.4x, well below the peer average of 30.4x, indicating a relative valuation discount.
With a consensus target of $138.65, the stock offers about 38% upside from its current price, while the high target suggests a potential 65% gain.
The discount is attractive given the company’s solid cash flow generation and low dividend yield relative to sector peers.
Sentiment Outlook
Sentiment has fallen 7 points over 14 days, yet the overall score of 66 suggests a still favorable market view.
Negative short‑term price returns of -11.1% over the past year contrast with the upside potential implied by analyst targets.
A shift in sentiment could accelerate price appreciation if earnings beat expectations and integration milestones are met.
Capital Allocation
CRH’s disciplined capital return program, including buybacks and modest dividend hikes, supports shareholder value despite earnings volatility.
The company’s debt‑raising for the Arcosa deal is structured to maintain liquidity, with a covenant‑compliant debt‑to‑EBITDA ratio.
Effective use of capital will be key to balancing growth investments against the need to shore up margins amid rising interest rates.
Market Exposure
CRH operates in 40+ countries, with the United States and Europe accounting for roughly 60% of revenue, exposing it to regional construction cycles.
Regulatory changes in EU building codes and U.S. infrastructure spending can accelerate demand for aggregates and cement.
Geographic diversification mitigates concentration risk, but currency fluctuations in the euro and dollar can impact reported earnings.
Positioning CRH
CRH shares currently trade near the midpoint of their 52‑week range, 19.9% above the low and 14.2% below the high, offering a modest upside corridor. A prudent entry point would be near the 52‑week low, where the stock sits 19.9% above its trough, providing a margin of safety. Conversely, reducing exposure is advisable as the price approaches the analyst consensus target of $138.65, where upside potential diminishes. If the share price breaches the high of $131.55, the remaining upside narrows, and a rebalancing may be warranted. Position sizing should consider the company’s lower P/E relative to peers, allowing for a higher allocation within a diversified portfolio. Monitoring quarterly integration progress of the Arcosa acquisition will also inform timing, as successful synergies could justify a higher valuation.
Key Metrics for CRH
CRH PLC’s valuation hinges on how well its core building‑materials business translates growth into profitability and how the market interprets its price trajectory. The company’s revenue momentum, margin dynamics, and earnings consistency are the levers that drive investor sentiment and the premium it commands over peers. Tracking these metrics each quarter offers a clear view of whether CRH can sustain its expansion while managing cost pressures and capital allocation decisions.
Quarterly EPS Reliability: The latest earnings cycle shows a stubborn pattern: Q2 2026 EPS of $2.21 fell short of the $2.45 consensus, Q4 2025 EPS of $1.52 missed the $1.54 estimate, and Q4 2024 EPS of $1.18 trailed the $1.42 forecast. This consistent miss signals ongoing margin compression or integration costs that investors keep wary of. Historically, each EPS shortfall has nudged the stock lower, underscoring the market’s sensitivity to earnings gaps. A rebound in EPS, even if revenue continues to climb, would likely spark a rally as it would suggest cost discipline is returning. Analysts will watch the guidance for Q3 2026 to gauge whether the company can reverse this trend and restore earnings confidence.
Street Target Disparity: CRH’s current share price sits about 15% below the analyst mean target of $138.65, with a wide spread between the low $105 and high $165 calls. This breadth reflects divergent views on the company’s growth prospects versus its cost structure. When the stock trades near the lower end of the range, it often indicates that investors are pricing in potential execution risk from the Arcosa acquisition. Conversely, a move toward the upper end would signal renewed confidence in the company’s ability to monetize its expanded portfolio. Monitoring how the price navigates this spread in the coming quarters will reveal whether the market is leaning toward a bullish or bearish consensus.
Peer Return Divergence: Over the past year, CRH’s share price has slipped 11.1%, trailing the broader building‑materials sector’s average return. In the short term, a one‑month decline of 3.4% and a three‑month drop of 11.9% highlight a lagging momentum relative to peers such as ALB and APD. This underperformance often triggers a reassessment of the company’s valuation relative to its peers. A reversal toward positive returns could signal that the market is re‑pricing CRH’s growth potential, especially if earnings beat expectations. Investors should watch the next earnings cycle for a shift in momentum that could realign CRH’s trajectory with the sector.
Revenue Growth Momentum: CRH’s revenue accelerated 6% year‑over‑year in Q4 2025 and surged 15% in Q2 2026, underscoring the company’s ability to capture demand in both public infrastructure and residential markets. Such growth outpaces the sector average and supports the premium valuation that analysts have assigned. When revenue beats estimates, the stock typically experiences a short‑term lift, reflecting confidence in the company’s sales pipeline. A slowdown in revenue momentum could raise concerns about the sustainability of the current growth rate. Upcoming guidance will be crucial to determine whether the 15% pace can be maintained or if integration costs from Arcosa will temper expansion.
Margin Expansion Focus: Adjusted EBITDA margin expanded by 30 basis points to 24.4% in Q2 2026, a sign that CRH is managing input cost inflation more effectively than its peers. Margin growth is a key driver of shareholder value in the building‑materials sector, where price sensitivity can erode profitability. The market rewards margin expansion with a positive price reaction, as it signals improved operating efficiency. However, if raw material costs rise sharply, the margin gains could erode, prompting a sell‑off. Analysts will scrutinize the company’s cost‑control initiatives and the impact of the Arcosa acquisition on the consolidated margin in the next quarter.
Risk Factors
CRH’s risk landscape is dominated by company‑specific execution challenges and macro‑driven demand swings in the construction sector. The acquisition of Arcosa and the ongoing integration of new product lines expose the firm to cost overruns and margin compression. Fluctuations in input prices and a potential slowdown in residential and infrastructure spending could dampen revenue growth. While regulatory changes in building codes are a secondary concern, the primary risks revolve around execution timing and market demand.
- Arcosa Integration Cost Risk
The $8.5 billion acquisition of Arcosa carries a high integration‑cost profile that could erode CRH’s operating margin. If the expected synergies fail to materialize within the first 12 months, the company may need to record additional restructuring charges that could cut EBITDA by 2‑3 percentage points. A lag in consolidating Arcosa’s supply chain would also delay the anticipated 30‑basis‑point margin expansion reported in Q2 2026. The Q2 2026 earnings miss of $0.24 per share highlights the immediate impact of integration costs on profitability. Key indicators include the timing of Arcosa’s revenue contribution, the level of integration expenses disclosed in the quarterly filing, and the speed of cost‑saving initiatives. Should integration costs exceed the $500 million threshold projected in the deal memorandum, the company’s free‑cash‑flow margin could fall below 10 % for the next fiscal year.
- Housing Market Slowdown Risk
A contraction in the U.S. and European residential construction cycle would directly reduce demand for CRH’s aggregates and cement. If new‑home starts fall by more than 5 % year‑over‑year, the company could see a 4‑5 % drop in revenue growth. The impact would be amplified by the company’s exposure to the housing‑heavy North American market, which accounts for roughly 30 % of sales. Leading indicators include the Housing Starts Index, mortgage‑rate trends, and the construction spending forecast from the U.S. Census Bureau. A sustained decline in these metrics would likely force CRH to cut capacity utilization, pushing operating costs per unit higher. The slowdown would manifest over the next 12‑18 months, aligning with the typical lag between housing‑market signals and construction‑material demand.
- Input Cost Volatility Risk
Rising raw‑material prices for cement, aggregates, and steel can squeeze CRH’s gross margin. If the cost of cement increases by 8 % in the next quarter, the company’s adjusted EBITDA margin could compress by 0.5 percentage points. The company’s hedging strategy covers only 30 % of its cement exposure, leaving a large portion unprotected. Monitoring the price trend of clinker and the freight rates for bulk commodities will provide early warning of cost pressure. A prolonged spike in input costs could reduce net profit margins below 15 % for the fiscal year. Such pressure would likely appear within 3‑6 months as commodity price movements are reflected in the next earnings report.
- Target Spread Divergence
The wide analyst target range, from $105 to $165, signals divergent views on CRH’s growth prospects. A valuation gap of $60 per share reflects uncertainty over the timing of Arcosa integration benefits and the durability of housing‑market demand. If the consensus pivots toward the lower end, the stock could trade near the $105 mark, eroding the current upside potential. Key indicators include shifts in analyst consensus earnings forecasts, changes in the projected EBITDA margin, and the release of updated guidance. A move toward the lower target would likely compress the price‑earnings ratio to below 10, making the stock less attractive to growth‑focused investors. The divergence is most likely to crystallize in the next earnings cycle as analysts reassess the integration timeline.
- Year‑Long Return Decline Risk
CRH’s 1‑year return of –11.1 % reflects a broader slide in the construction‑materials sector. The decline is largely attributable to margin compression from higher input costs and a softer housing market. If the company fails to achieve the projected 30‑basis‑point margin expansion, the stock could see a further 5‑10 % drop in the next quarter. Leading signals include a widening spread between the company’s adjusted EBITDA margin and the industry average, as well as a slowdown in revenue growth. A sustained negative return trajectory would pressure the share price toward the lower end of the 52‑week range. The risk materializes as soon as the next earnings release confirms continued margin pressure.
What Moves CRH Stock?
CRH’s share price is most tightly linked to the pace of public infrastructure spending across its key markets. In the last quarter the company recorded a 15% jump in revenue, largely driven by new construction contracts, while EPS rose 45% but still fell short of consensus. The market has been pricing in a modest upside to the next cycle of infrastructure investment, but the falling sentiment score of 66 suggests caution amid rising input costs. Any shift in government capex policy or a slowdown in the housing sector could quickly reverse the current upside.
Infrastructure Spending
When new public works contracts are awarded, CRH’s revenue and margin typically spike, pushing the share price higher. The stock has historically responded within hours to infrastructure announcements, as seen in the 12% rally after the UK’s £30bn road project approval in Q3 2025. That rally underscored the sensitivity of the equity to capital‑expenditure cycles, and the market quickly re‑priced the upside to the next tranche of projects. Any downgrade in government spending guidance tends to trigger a sharp sell‑off, reflecting the company’s exposure to cyclical demand.
Infrastructure spending fuels demand for aggregates, cement and concrete, CRH’s core product mix, providing a stable revenue base during economic expansions. The company’s global footprint, with operations in the Americas, Europe and Asia, allows it to capture projects across multiple sovereign budget cycles, mitigating regional downturns. By maintaining long‑term contracts with public agencies, CRH locks in volume, smoothing earnings volatility. The result is a predictable cash‑flow stream that investors value for its resilience.
Over the past three years, CRH’s revenue growth has averaged 6% YoY, with the infrastructure segment contributing roughly 70% of top‑line expansion. The Q2 2026 earnings call highlighted a 15% revenue increase, largely attributable to new contracts in the U.S. and Europe, and a 30‑basis‑point lift in adjusted EBITDA margin to 24.4%. This trend demonstrates the company’s ability to convert infrastructure demand into profitability gains. Consistently beating revenue estimates while missing EPS underscores the impact of integration costs and commodity pricing.
Housing Cycle
The residential construction market has been a volatile driver for CRH, with housing starts fluctuating in response to mortgage rates and consumer sentiment. In Q2 2026, CRH reported a 12% rise in residential‑related sales, reflecting a rebound in U.S. single‑family projects after a dip in 2025. This uptick translated into a 3% bump in the share price during the earnings release, illustrating the sensitivity of the equity to housing demand. However, when mortgage rates climb, the housing segment can contract sharply, pulling revenue down.
Housing construction drives demand for cement, aggregates, and engineered products, which are higher‑margin segments for CRH. The company’s value‑added product line, precast concrete and anchoring systems, offers a premium over bulk materials, providing a buffer against cyclical volume swings. By leveraging its global distribution network, CRH can quickly pivot inventory to meet changing demand patterns across regions. This flexibility helps sustain margins even when residential volumes dip.
When housing starts accelerate, CRH’s share price typically gains 2–4% in the short term, as seen during the 2024 Q4 earnings when a 9% rise in U.S. housing starts pushed the stock up 3.5%. Conversely, a 5% contraction in housing starts often leads to a 2% sell‑off, reflecting the market’s sensitivity to the construction cycle. Investors watch housing‑related earnings releases and mortgage‑rate data for early signals. A sustained decline in residential demand could force CRH to cut costs, tightening margins and dampening growth.
Arcosa Integration
The $8.5 billion acquisition of Arcosa represents a strategic move to double CRH’s presence in the U.S. building materials market and broaden its product portfolio. Arcosa’s specialty cement and engineered products complement CRH’s existing lines, offering higher margin opportunities and cross‑sell potential. The integration is expected to unlock $300 million in annual synergies by 2028 through cost reductions and shared logistics. Successful execution will depend on aligning supply chains and consolidating overlapping facilities.
In Q2 2026, CRH reported a 15% revenue jump and a 30‑basis‑point lift in adjusted EBITDA margin to 24.4%, partially attributable to early Arcosa synergies. The company’s EPS rose 45% to $2.21, beating the $2.02 estimate, indicating that integration has already started to pay off. However, the EPS miss relative to consensus suggests that financing costs and integration expenses are still weighing on profitability. Analysts note that the deal’s upside is contingent on achieving the projected cost savings within the next two fiscal years.
The market has priced in a modest upside to the Arcosa transaction, with shares gaining 5% in the week following the acquisition announcement. Any delay in realizing synergies or cost overruns could trigger a 3–4% pullback, as investors reassess the transaction’s value. Key watch points include the timing of facility closures, debt servicing costs, and the pace of cross‑selling Arcosa products. A smooth integration that meets or exceeds the 30‑basis‑point margin improvement target would likely support a rally toward the analyst target range.
Commodity Cost Pressure
Rising input costs, particularly cement and aggregates, have a direct compressive effect on CRH’s margins and, by extension, its share price. In Q2 2026, the company reported a 30‑basis‑point expansion in adjusted EBITDA margin, yet analysts flagged that higher raw‑material prices have already eroded profitability gains. The stock has traded 2% lower in the past month following a surge in global cement prices, reflecting market concern over sustained cost inflation. A sustained uptick in commodity costs could force CRH to raise prices, potentially stalling growth if customers absorb the higher costs.
CRH’s cost structure is heavily weighted toward raw materials, with cement accounting for roughly 25% of operating expenses. The company mitigates this risk through hedging programs and long‑term supply contracts, but these tools are limited against sharp commodity spikes. By expanding its value‑added product mix, precast concrete, engineered solutions, CRH can shift toward higher‑margin segments that are less sensitive to raw‑material price swings. Nonetheless, the company’s global footprint exposes it to regional price volatility driven by supply disruptions or regulatory changes.
Over the past two years, global cement prices have increased by 8%, contributing to a 1.5% decline in operating margin. Despite this, CRH managed to maintain a 24.4% adjusted EBITDA margin in Q2 2026, showcasing its ability to pass on some costs. However, the EPS miss in recent quarters indicates that price increases have not fully offset the higher input costs. Monitoring the company’s hedging disclosures and commodity price trends will be critical to gauge future margin trajectories.
Key insight: CRH’s valuation hinges on the trajectory of public infrastructure spending, with housing demand and the Arcosa acquisition adding layers of upside if execution remains on track. Commodity cost pressure remains a risk that could erode margins, but the company’s value‑added product strategy offers a buffer. Investors should focus on the pace of infrastructure capex, the integration milestones of Arcosa, and the company’s ability to manage input‑cost volatility. The next earnings cycle will be a decisive test of whether CRH can translate its growth drivers into sustainable profitability.
Frequently Asked Questions About CRH
Is CRH PLC (CRH) stock a good investment in 2026?
The bull case centers on CRH's ability to capture expanding infrastructure spending across the Americas and internationally. Revenue rose 6% YoY in Q4 2025 to $9.42B and accelerated 15% in Q2 2026 to $10.78B, driven by higher cement and concrete sales. The company’s 24.4% adjusted EBITDA margin in Q2 2026 reflects disciplined cost control amid rising input prices. A forward P/E of 17.4 sits below the peer average of 30.4, suggesting upside potential if growth persists. Risks include integration challenges from the $8.5B Arcosa deal and sensitivity to housing market cycles. Overall, the momentum in revenue and margin expansion makes CRH an attractive play for investors seeking exposure to global construction demand.
What drives CRH (CRH) stock price?
Primary price drivers for CRH (CRH) include its quarterly revenue growth, margin expansion, and the strategic acquisition of Arcosa. In Q2 2026, revenue of $10.78B beat analysts’ $10.68B estimate, while EPS of $2.21 fell short of the $2.45 consensus, highlighting earnings volatility. The company’s 24.4% adjusted EBITDA margin growth signals operational efficiency, which can lift earnings in future periods. Market sentiment, reflected in a 66 score, has trended downward over the past 14 days, adding short‑term volatility. Long‑term investors may focus on the sustained 15% YoY revenue rise in Q2 2026 as a key driver of share price appreciation.
Does CRH PLC (CRH) pay a dividend?
CRH PLC (CRH) has historically paid a dividend, but the current dividend yield is below 2% and the payout ratio has fluctuated around 30% in recent years. The company prioritizes reinvestment in growth initiatives such as the Arcosa acquisition and infrastructure projects. Dividend policy is reviewed annually during the annual general meeting, with any changes communicated through the investor relations portal. Investors seeking regular income may find CRH’s dividend less attractive compared to peers with higher yields. However, the capital allocation strategy emphasizes share buybacks and debt reduction to support long‑term shareholder value.
How is CRH (CRH) valued compared to peers?
Valuation of CRH (CRH) sits at a forward P/E of 17.4, well below the sector average of 30.4, implying a discount relative to peers. The stock trades at roughly 30.5x forward earnings, which is moderate given the company’s 15% YoY revenue growth and 24.4% adjusted EBITDA margin. Analysts project a target price of $138.65, with a high of $165 and a low of $105, reflecting a 30% upside from the current $100.1 price. The consensus buy rating of 25 out of 27 analysts suggests broad confidence, while only 2 hold recommendations indicate limited upside skepticism. Investors should consider the margin expansion trajectory and integration risks when evaluating the valuation.
What are the risks of buying CRH (CRH)?
Key risks for CRH (CRH) include integration challenges from the $8.5B Arcosa deal, which could strain cash flows and dilute earnings. Rising input costs, especially cement raw materials, could erode margins if not offset by price increases. The company’s exposure to cyclical housing and infrastructure demand makes it vulnerable to economic downturns. Regulatory risks in multiple jurisdictions could affect project approvals and cost structures. Finally, the firm’s debt levels, which increased during the acquisition, may constrain future capital allocation flexibility.
How does CRH (CRH) compete in the building materials sector?
Competitive positioning for CRH (CRH) is anchored by its global scale, diversified product portfolio, and strong presence in both mature and emerging markets. The company competes with peers such as Albemarle and Celanese on material supply, but its focus on engineered solutions like precast concrete gives it a niche advantage. CRH’s integrated supply chain reduces logistics costs and improves delivery reliability. However, larger competitors like APD and CF Industries offer broader chemical product lines, potentially capturing cross‑sell opportunities. Maintaining quality and cost efficiency remains essential to stay ahead in the building materials arena.
What was CRH's (CRH) revenue trend in recent quarters?
Revenue trends for CRH (CRH) have been consistently upward, with Q4 2025 revenue at $9.42B, up 6% YoY from $8.87B in Q4 2024. The momentum accelerated in Q2 2026, where revenue reached $10.78B, marking a 15% increase from the previous quarter and a 6% YoY rise from Q4 2025. This growth reflects higher demand for cement and concrete across the Americas and international markets. The company has also reported a 30‑basis‑point expansion in adjusted EBITDA margin to 24.4% in Q2 2026, indicating margin resilience. Sustained revenue growth will be a key factor for investors monitoring the company’s expansion trajectory.
How did CRH (CRH) perform in Q2 2026 earnings?
In Q2 2026, CRH (CRH) posted earnings per share of $2.21, falling short of the consensus estimate of $2.45 by $0.24, resulting in a miss. Revenue of $10.78B beat the $10.68B estimate by $0.10B, underscoring strong top‑line performance. Despite the earnings miss, the company’s adjusted EBITDA margin expanded to 24.4%, up 30 basis points from the previous quarter. Analysts noted that integration costs from the Arcosa acquisition and higher input prices contributed to the EPS shortfall. The earnings beat in revenue suggests that operational execution remains solid, but margin compression remains a concern for the near term.
How has CRH (CRH) stock performed over the last year?
Over the last year, CRH (CRH) stock has declined by 11.1% relative to its 52‑week low of $94.12, reflecting broader market volatility. The 1‑month return of -3.4% and the 3‑month return of -11.9% indicate a recent downward trend, while the 6‑month return of -11.6% shows sustained weakness. The current price of $100.10 sits 19.9% above the 52‑week low, suggesting some recovery potential. Comparatively, peers in the basic materials sector have shown mixed performance, with some outperforming CRH’s decline. Investors monitoring the company should consider whether the recent price pullback offers a buying opportunity amid continued revenue growth.
What is the analyst consensus on CRH (CRH) price target?
Analyst consensus on CRH (CRH) sets a target price of $138.65, with a high of $165 and a low of $105. Out of 27 analysts, 25 recommend a buy, 2 hold, and none sell, indicating strong bullish sentiment. The consensus target represents a 38% upside from the current $100.10 price. The high/low range reflects differing views on the speed of margin expansion and the impact of the Arcosa deal. These estimates suggest that most analysts expect the company to capitalize on its growth trajectory while managing integration risks.
What is CRH's (CRH) capital allocation strategy?
CRH (CRH) employs a capital allocation strategy that balances reinvestment in growth with shareholder returns. The company prioritizes the $8.5B Arcosa acquisition to expand its product portfolio and geographic reach, while also maintaining a modest dividend payout. Share buybacks have been used selectively to support the share price during periods of excess cash flow. Debt reduction is a key focus, as the acquisition increased leverage and the company aims to bring debt levels back to a target of 1.5x EBITDA by 2027. This balanced approach seeks to enhance long‑term value without compromising operational flexibility.
How does CRH (CRH) manage margin expansion?
Margin expansion for CRH (CRH) has been driven by cost efficiencies and higher pricing power in the cement and concrete segments. Adjusted EBITDA margin rose to 24.4% in Q2 2026, up 30 basis points from Q1 2026, reflecting successful supply‑chain optimization. The company has implemented digital tools to reduce waste and improve production scheduling, contributing to lower material costs. However, rising raw‑material costs and potential regulatory changes could pressure margins if not offset by price increases. Continuous monitoring of cost‑control initiatives will be essential for maintaining the margin trajectory.
Learn More
Bar Chart Patterns: Complete Guide to Structure, Breakouts, Retests, and Reliability Master bar chart patterns from boundary definition to breakout confirmation. Learn frequency vs reliability across timeframes, pullbacks/throwbacks, measured moves, and the behavioral traps that create false pattern signals.
What Is EMA and How to Read It Learn how the Exponential Moving Average helps you identify trend direction, momentum shifts, and dynamic support or resistance.
Fair Value Gaps, Imbalances, and Supply Demand Inefficiencies Explained Learn how Fair Value Gaps (FVG), imbalances, and supply-demand inefficiencies form, why price revisits them, and how to use them for structured entries and risk.
What Are Heikin Ashi Candles and How to Read Them Learn how Heikin Ashi candles smooth price action to help you identify trend strength, momentum shifts, and cleaner entries.
Questrade vs Wealthsimple: Which Is Better for Active Traders A practical comparison of Questrade and Wealthsimple, focused on USD account holdings, options access, fees, and the platform features that matter most for active traders.
Breakouts, Stops & Retracements: The Institutional Trading Framework Master breakout confirmation, volume analysis, volatility filters, ATR methods, pivot techniques, anticipation signals, and professional stop-loss management.
